Douglas K. Bratton - Dec 31, 2024 SCHEDULE 13G/A Report for Aquestive Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share (AQST)

Filing Manager
Douglas K. Bratton
Reporting Manager
BRATTON DOUGLAS K
Security
Aquestive Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share
Symbol
AQST
Shares outstanding
90.8M shares
Disclosed Ownership
10.1M shares
Ownership
11.1%
Form type
SCHEDULE 13G/A
Date filed
2/13/2025, 11:38 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BRATTON DOUGLAS K 11.1% 10.1M 10M 0 Douglas K. Bratton Individual
MonoLine RX II, L.P. 3.8% 3.47M 3.47M 0 John Cochran Vice President of General Partner of General Partner
MonoLine RX III, L.P. 2.9% 2.66M 2.66M 0 John Cochran Vice President of General Partner of General Partner
MonoLine RX, L.P. 1.9% 1.69M 1.69M 0 John Cochran Vice President of General Partner of General Partner
MonoLine Partners, L.P. 2.1% 1.95M 1.95M 0 John Cochran Vice President of General Partner of General Partner
MonoSol Rx Genpar, L.P. 0.1% 47.1K 47.1K 0 John Cochran Vice President of General Partner